Article
Increased constitutive activity of PKB/Akt in tamoxifen resistant breast cancer MCF-7 cells.
Breast cancer research and treatment - 1 Sept 2004
Jordan Nicola J, Gee Julia M W, Barrow Denise, Wakeling Alan E, Nicholson Robert I
Abstract excerpt
The tamoxifen-resistant (TAM-R) MCF-7 breast cancer cell line has been used as a model to identify the signalling pathways that enable resistant cancer cells to grow independently of steroid hormones. In TAM-R cells, peptide growth factor signalling pathways appear to be important in modified cell behaviour, growth and survival. The PI3 kinase signalling components Akt1 and Akt2 are expressed at similar levels by...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
